S100A10 is involved in various cellular processes, regulates plasminogen activation [60] and has been shown to suppress pro-apoptotic capacity of Bcl-2-associated death protein (BAD), which is suggested to have anti-apoptotic function in cancer cells (reviewed in [61]). The gene discussed is BAD; the disease is cancer.